-+ 0.00%
-+ 0.00%
-+ 0.00%

PURPLE BIOTECH REPORTS POSITIVE NEW PRECLINICAL DATA DEMONSTRATING MULTI-ARM ANTI-TUMOR ACTIVITY ACROSS TWO CAPTN-3 TRI-SPECIFIC ANTIBODIES AT ESMO IMMUNO-ONCOLOGY CONGRESS 2025

路透·12/11/2025 12:00:01

登錄查看新聞詳情